US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 2.220
  • -0.090-3.90%
Close Jun 28 16:00 ET
  • 2.240
  • +0.020+0.90%
Post 19:59 ET
420.60MMarket Cap-2466P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
199.03%53.83M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
38.07%-42.83M
-5.57%-50.53M
Net income from continuing operations
198.87%61.02M
10.45%-209.25M
-1.54%-56.34M
25.16%-41.25M
24.71%-49.94M
-8.79%-61.72M
13.17%-233.66M
14.79%-55.49M
20.56%-55.12M
-51.88%-66.32M
Depreciation and amortization
--0
-67.20%164K
-93.48%6K
-75.24%26K
-66.00%51K
-47.06%81K
-18.30%500K
-39.87%92K
-31.37%105K
-1.96%150K
Other non cash items
-3.09%11.37M
4.69%48.38M
6.22%12.41M
7.33%12.35M
2.34%11.89M
2.84%11.74M
30.07%46.21M
6.15%11.68M
5.96%11.5M
39.20%11.62M
Change In working capital
-210.63%-21.8M
505.43%13.68M
278.72%3.96M
317.34%6.58M
3,275.42%10.16M
-548.21%-7.02M
93.58%-3.37M
60.37%-2.21M
81.42%-3.03M
101.41%301K
-Change in receivables
-127.77%-6.12M
-36.78%-14.77M
-162.10%-5.87M
49.96%-1.82M
-60.70%-4.38M
-23.10%-2.69M
-2.36%-10.8M
-83.01%-2.24M
-2,631.25%-3.65M
39.70%-2.73M
-Change in inventory
-80.00%-7.47M
-3,669.76%-30.42M
-150.85%-14.19M
-1,739.94%-5.76M
-198.47%-6.32M
-229.44%-4.15M
95.58%-807K
-1,240.28%-5.66M
96.95%-313K
274.32%6.42M
-Change in prepaid assets
-309.83%-6.59M
336.36%6.19M
794.98%4.64M
-16.35%-2.16M
167.34%5.32M
-310.47%-1.61M
1,333.33%1.42M
151.96%518K
-107.27%-1.85M
-70.97%1.99M
-Change in payables and accrued expense
22.88%-5.57M
219.91%30.78M
140.21%13.7M
207.42%12.23M
288.46%12.07M
-213.87%-7.22M
135.40%9.62M
240.64%5.7M
194.58%3.98M
71.37%-6.41M
-Change in other working capital
-54.36%3.95M
879.18%21.9M
1,155.58%5.68M
442.46%4.09M
240.22%3.48M
511.90%8.65M
-160.37%-2.81M
-122.38%-538K
-11.17%-1.19M
-58.18%1.02M
Cash from discontinued investing activities
Operating cash flow
199.03%53.83M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
38.07%-42.83M
-5.57%-50.53M
Investing cash flow
Cash flow from continuing investing activities
-100.29%-73K
424.43%42.5M
0
0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
33M
5M
Net PPE purchase and sale
---73K
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
--0
424.43%42.5M
--0
--0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
--33M
--5M
Cash from discontinued investing activities
Investing cash flow
-100.29%-73K
424.43%42.5M
--0
--0
250.00%17.5M
238.11%25M
116.05%8.1M
76.64%-11.79M
--33M
--5M
Financing cash flow
Cash flow from continuing financing activities
83.07%90.61M
54.76%50.46M
114.73%4.47M
-109.31%-4.31M
-95.53%809K
3,546.52%49.49M
-87.84%32.61M
-114.23%-30.36M
1,166.54%46.29M
-63.13%18.11M
Net common stock issuance
72.39%90.67M
-37.40%56.88M
138.44%52.43M
-207.82%-52.46M
-78.68%4.31M
--52.6M
-58.46%90.85M
-89.74%21.99M
1,008.75%48.65M
--20.21M
Cash dividends paid
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--5.77M
--9.09M
---43.36M
--52.44M
--10K
--0
--0
--0
--0
----
Net other financing activities
----
----
----
----
----
----
-201.24%-50.22M
-40,100.00%-50M
--0
--0
Cash from discontinued financing activities
Financing cash flow
83.07%90.61M
54.76%50.46M
114.73%4.47M
-109.31%-4.31M
-95.53%809K
3,546.52%49.49M
-87.84%32.61M
-114.23%-30.36M
1,166.54%46.29M
-63.13%18.11M
Net cash flow
Beginning cash position
-34.08%82.25M
-51.80%124.78M
-45.16%114.83M
-19.93%138.47M
-27.68%144.91M
-51.80%124.78M
-15.11%258.89M
36.26%209.4M
-21.10%172.94M
-8.06%200.36M
Current changes in cash
616.93%144.36M
68.29%-42.53M
61.49%-32.59M
-164.83%-23.64M
76.51%-6.44M
134.40%20.14M
-191.12%-134.12M
-180.43%-84.62M
155.65%36.46M
-2,299.20%-27.42M
End cash Position
56.38%226.61M
-34.08%82.25M
-34.08%82.25M
-45.16%114.83M
-19.93%138.47M
-27.68%144.91M
-51.80%124.78M
-51.80%124.78M
36.26%209.4M
-21.10%172.94M
Free cash flow
198.89%53.76M
22.50%-135.49M
12.75%-37.06M
54.88%-19.33M
51.02%-24.75M
-39.41%-54.36M
33.73%-174.83M
26.40%-42.47M
38.07%-42.83M
-5.57%-50.53M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 199.03%53.83M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M38.07%-42.83M-5.57%-50.53M
Net income from continuing operations 198.87%61.02M10.45%-209.25M-1.54%-56.34M25.16%-41.25M24.71%-49.94M-8.79%-61.72M13.17%-233.66M14.79%-55.49M20.56%-55.12M-51.88%-66.32M
Depreciation and amortization --0-67.20%164K-93.48%6K-75.24%26K-66.00%51K-47.06%81K-18.30%500K-39.87%92K-31.37%105K-1.96%150K
Other non cash items -3.09%11.37M4.69%48.38M6.22%12.41M7.33%12.35M2.34%11.89M2.84%11.74M30.07%46.21M6.15%11.68M5.96%11.5M39.20%11.62M
Change In working capital -210.63%-21.8M505.43%13.68M278.72%3.96M317.34%6.58M3,275.42%10.16M-548.21%-7.02M93.58%-3.37M60.37%-2.21M81.42%-3.03M101.41%301K
-Change in receivables -127.77%-6.12M-36.78%-14.77M-162.10%-5.87M49.96%-1.82M-60.70%-4.38M-23.10%-2.69M-2.36%-10.8M-83.01%-2.24M-2,631.25%-3.65M39.70%-2.73M
-Change in inventory -80.00%-7.47M-3,669.76%-30.42M-150.85%-14.19M-1,739.94%-5.76M-198.47%-6.32M-229.44%-4.15M95.58%-807K-1,240.28%-5.66M96.95%-313K274.32%6.42M
-Change in prepaid assets -309.83%-6.59M336.36%6.19M794.98%4.64M-16.35%-2.16M167.34%5.32M-310.47%-1.61M1,333.33%1.42M151.96%518K-107.27%-1.85M-70.97%1.99M
-Change in payables and accrued expense 22.88%-5.57M219.91%30.78M140.21%13.7M207.42%12.23M288.46%12.07M-213.87%-7.22M135.40%9.62M240.64%5.7M194.58%3.98M71.37%-6.41M
-Change in other working capital -54.36%3.95M879.18%21.9M1,155.58%5.68M442.46%4.09M240.22%3.48M511.90%8.65M-160.37%-2.81M-122.38%-538K-11.17%-1.19M-58.18%1.02M
Cash from discontinued investing activities
Operating cash flow 199.03%53.83M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M38.07%-42.83M-5.57%-50.53M
Investing cash flow
Cash flow from continuing investing activities -100.29%-73K424.43%42.5M00250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M33M5M
Net PPE purchase and sale ---73K------------------0----------------
Net investment purchase and sale --0424.43%42.5M--0--0250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M--33M--5M
Cash from discontinued investing activities
Investing cash flow -100.29%-73K424.43%42.5M--0--0250.00%17.5M238.11%25M116.05%8.1M76.64%-11.79M--33M--5M
Financing cash flow
Cash flow from continuing financing activities 83.07%90.61M54.76%50.46M114.73%4.47M-109.31%-4.31M-95.53%809K3,546.52%49.49M-87.84%32.61M-114.23%-30.36M1,166.54%46.29M-63.13%18.11M
Net common stock issuance 72.39%90.67M-37.40%56.88M138.44%52.43M-207.82%-52.46M-78.68%4.31M--52.6M-58.46%90.85M-89.74%21.99M1,008.75%48.65M--20.21M
Cash dividends paid --0--0--0--0--0--0--0--0--0--0
Proceeds from stock option exercised by employees --5.77M--9.09M---43.36M--52.44M--10K--0--0--0--0----
Net other financing activities -------------------------201.24%-50.22M-40,100.00%-50M--0--0
Cash from discontinued financing activities
Financing cash flow 83.07%90.61M54.76%50.46M114.73%4.47M-109.31%-4.31M-95.53%809K3,546.52%49.49M-87.84%32.61M-114.23%-30.36M1,166.54%46.29M-63.13%18.11M
Net cash flow
Beginning cash position -34.08%82.25M-51.80%124.78M-45.16%114.83M-19.93%138.47M-27.68%144.91M-51.80%124.78M-15.11%258.89M36.26%209.4M-21.10%172.94M-8.06%200.36M
Current changes in cash 616.93%144.36M68.29%-42.53M61.49%-32.59M-164.83%-23.64M76.51%-6.44M134.40%20.14M-191.12%-134.12M-180.43%-84.62M155.65%36.46M-2,299.20%-27.42M
End cash Position 56.38%226.61M-34.08%82.25M-34.08%82.25M-45.16%114.83M-19.93%138.47M-27.68%144.91M-51.80%124.78M-51.80%124.78M36.26%209.4M-21.10%172.94M
Free cash flow 198.89%53.76M22.50%-135.49M12.75%-37.06M54.88%-19.33M51.02%-24.75M-39.41%-54.36M33.73%-174.83M26.40%-42.47M38.07%-42.83M-5.57%-50.53M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg